Information Gathering and Verification Survey for Promoting Research and Development (R&D) and Production Base Development for Vaccines and Pharmaceuticals Worldwide

This JICA consultancy tender focuses on a worldwide information gathering and verification survey aimed at promoting research and development (R&D) and the strengthening of production bases for vaccines and pharmaceuticals. The objective is to identify global needs, challenges, and opportunities in enhancing the capacity for developing and manufacturing essential medical products. The survey will explore effective strategies and potential areas for JICA's support, including technological advancements, regulatory frameworks, and international cooperation. It seeks to understand how to foster innovation and ensure a stable supply of vaccines and pharmaceuticals, particularly in response to global health crises. The findings are intended to inform JICA's future interventions and partnerships in the health sector, contributing to global health security and equitable access to medical countermeasures. This initiative highlights JICA's commitment to addressing critical global health challenges through strategic investments and knowledge sharing.

This is a consulting contract in the health and medical services, trade and industry and Research sectors, with a focus on Pharmaceuticals, Food Beverage and Technology Transfer. Located in Global, Asia, this opportunity is open to firms and consortiums.

Published through JICA - Japan International Cooperation Agency, a bilateral development cooperation agency. Bilateral agency contracts follow the agency's own procurement guidelines and may have nationality-based eligibility rules for consulting in the health and medical services sector. Consulting assignments are typically evaluated with a strong emphasis on the technical proposal, including the methodology and qualifications of key experts. Shortlisted firms may be invited to submit financial proposals in a second stage. This is a shortlist announcement indicating that firms have been pre-selected for the next phase of the procurement process.